The role of vitamin D in inflammatory bowel disease: a guide for clinical practice

References

• Cantorna MT, Rogers CJ, Arora J. Aligning the paradoxical role of vitamin D in gastrointestinal immunity. Trends Endocrinol Metab. 2019;30:459–466..
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Mullin GE, Limsui D, et al. Role of vitamin D in inflammatory bowel disease. Nutr Clin Pract. 2017;32:337–345.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281.
   PubMed Web of Science ®Google Scholar
• Holick MF, MacLaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980;210:203–205.
   PubMed Web of Science ®Google Scholar
• Tian XQ, Chen TC, Matsuoka LY, et al. Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem. 1993;268:14888–14892.
   PubMed Web of Science ®Google Scholar
• Ponchon G, DeLuca HF. The role of the liver in the metabolism of vitamin D. J Clin Invest. 1969;48:1273–1279.
   PubMed Web of Science ®Google Scholar
• Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970;228:764–766.
   PubMed Web of Science ®Google Scholar
• Haussler MR, Norman AW. Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci USA. 1969;62:155–162.
   PubMed Web of Science ®Google Scholar
• Mesbah M, Nemere I, Papagerakis P, et al. Expression of a 1,25-dihydroxyvitamin D3 membrane-associated rapid-response steroid binding protein during human tooth and bone development and biomineralization. J Bone Miner Res. 2002;17:1588–1596.
   PubMed Web of Science ®Google Scholar
• Nemere I, Garbi N, Hammerling G, et al. Role of the 1,25D3-MARRS receptor in the 1,25(OH)2D3-stimulated uptake of calcium and phosphate in intestinal cells. Steroids. 2012;77:897–902.
   PubMed Web of Science ®Google Scholar
• Pramyothin P, Holick M. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol. 2012;28:139–150.
   PubMed Web of Science ®Google Scholar
• Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294:G208–216.
   PubMed Web of Science ®Google Scholar
• He L, Liu T, Shi Y, et al. Gut epithelial vitamin D receptor regulates microbiota-dependent mucosal inflammation by suppressing intestinal epithelial cell apoptosis. Endocrinology. 2018;159:967–979.
   PubMed Web of Science ®Google Scholar
• Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol. 2012;12:57.
   PubMed Web of Science ®Google Scholar
• Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate–induced colitis. J Nutr. 2013;143:1679–1686.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen Y, Golan MA, et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest. 2013;123:3983–3996.
   PubMed Web of Science ®Google Scholar
• Sadeghi K, Wessner B, Laggner U, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36:361–370.
   PubMed Web of Science ®Google Scholar
• Griffin MD, Lutz W, Phan VA, et al. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA. 2001;98:6800–6805.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest. 1998;101:252–262.
   PubMed Web of Science ®Google Scholar
• Reichel H, Koeffler HP, Norman AW. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem. 1987;262:10931–10937.
   PubMed Web of Science ®Google Scholar
• Fritsche J, Mondal K, Ehrnsperger A, et al. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood. 2003;102:3314–3316.
   PubMed Web of Science ®Google Scholar
• Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–1647.
   PubMed Web of Science ®Google Scholar
• Manolagas SC, Provvedini DM, Murray EJ, et al. The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells. J Clin Endocrinol Metab. 1986;63:394–400.
   PubMed Web of Science ®Google Scholar
• Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984;224:1438–1440.
   PubMed Web of Science ®Google Scholar
• Daniel C, Sartory NA, Zahn N, et al. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008;324:23–33.
   PubMed Web of Science ®Google Scholar
• Ghoreishi M, Bach P, Obst J, et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol. 2009;182:6071–6078.
   PubMed Web of Science ®Google Scholar
• Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183:5458–5467.
   PubMed Web of Science ®Google Scholar
• Alroy I, Towers TL, Freedman LP. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995;15:5789–5799.
   PubMed Web of Science ®Google Scholar
• Bhalla AK, Amento EP, Krane SM. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol. 1986;98:311–322.
   PubMed Web of Science ®Google Scholar
• Palmer MT, Lee YK, Maynard CL, et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem. 2011;286:997–1004.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Lin Y-D, Arora J, et al. Vitamin D regulates the microbiota to control the numbers of RORγt/FoxP3+ regulatory T cells in the colon. Front Immunol. 2019;10:1772.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229: 1136–1142..
   PubMed Web of Science ®Google Scholar
• Yu S, Bruce D, Froicu M, et al. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA. 2008;105:20834–20839.
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Munsick C, Bemiss C, et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130:2648–2652.
   PubMed Web of Science ®Google Scholar
• Froicu M, Weaver V, Wynn TA, et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003;17:2386–2392.
   PubMed Web of Science ®Google Scholar
• Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007;8:5.
   PubMed Web of Science ®Google Scholar
• Lagishetty V, Misharin AV, Liu NQ, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423–2432.
   PubMed Web of Science ®Google Scholar
• Golan MA, Liu W, Shi Y, et al. Transgenic expression of vitamin D receptor in gut epithelial cells ameliorates spontaneous colitis caused by interleukin-10 deficiency. Dig Dis Sci. 2015;60:1941–1947.
   PubMed Web of Science ®Google Scholar
• Schardey J, Globig A-M, Janssen C, et al. Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease. J Crohns Colitis. 2019;13:1546–1557.
   PubMed Web of Science ®Google Scholar
• Bartels LE, Jørgensen SP, Bendix M, et al. 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease. Inflammopharmacology. 2013;21:177–186.
   PubMed Web of Science ®Google Scholar
• Bartels LE, Bendix M, Hvas CL, et al. Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients. Inflammopharmacology. 2014;22:95–103.
   PubMed Web of Science ®Google Scholar
• Gubatan J, Mehigan GA, Villegas F, et al. Cathelicidin mediates a protective role of vitamin D in ulcerative colitis and human colonic epithelial cells. Inflamm Bowel Dis. 2020. DOI:10.1093/ibd/izz330.
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157:647–659.e4..
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–697.
   PubMed Web of Science ®Google Scholar
• Nerich V, Jantchou P, Boutron-Ruault M-C, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33:940–945.
   PubMed Web of Science ®Google Scholar
• Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12:218–226.
   PubMed Web of Science ®Google Scholar
• Nerich V, Monnet E, Weill A, et al. Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis. 2010;16:813–821.
   PubMed Web of Science ®Google Scholar
• Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn’s disease in Scotland: association with northern latitude and affluence. Gastroenterology. 2004;127:1051–1057.
   PubMed Web of Science ®Google Scholar
• Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61:1686–1692.
   PubMed Web of Science ®Google Scholar
• Sonnenberg A, Genta RM. Geographic distributions of microscopic colitis and inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2012;18:2288–2293.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142:482–489.
   PubMed Web of Science ®Google Scholar
• Limketkai BN, Singla MB, Rodriguez B, et al. Levels of vitamin D are low after Crohn’s disease is established but not before. Clin Gastroenterol Hepatol. 2019. DOI:10.1016/j.cgh.2019.09.034.
   Web of Science ®Google Scholar
• Lund-Nielsen J, Vedel-Krogh S, Kobylecki CJ, et al. Vitamin D and inflammatory bowel disease: mendelian randomization analyses in the copenhagen studies and UK biobank. J Clin Endocrinol Metab. 2018;103:3267–3277.
   PubMed Web of Science ®Google Scholar
• Opstelten JL, Chan SSM, Hart AR, et al. Prediagnostic serum vitamin D levels and the risk of Crohn’s disease and ulcerative colitis in european populations: a nested case-control study. Inflamm Bowel Dis. 2018;24:633–640.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19:1921–1927.
   PubMed Web of Science ®Google Scholar
• Kabbani TA, Koutroubakis IE, Schoen RE, et al. Association of vitamin D level with clinical status in inflammatory bowel disease: A 5-year longitudinal study. Am J Gastroenterol. 2016;111:712–719.
   PubMed Web of Science ®Google Scholar
• Gubatan J, Mitsuhashi S, Zenlea T, et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2017;15:240–246.e1.
   PubMed Web of Science ®Google Scholar
• Frigstad SO, Høivik M, Jahnsen J, et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017;52:100–106.
   PubMed Web of Science ®Google Scholar
• Winter RW, Collins E, Cao B, et al. Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-α medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45:653–659.
   PubMed Web of Science ®Google Scholar
• Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38:385–391.
   PubMed Web of Science ®Google Scholar
• Santos-Antunes J, Nunes AC-R, Lopes S, et al. The relevance of vitamin D and antinuclear antibodies in patients with inflammatory bowel disease under anti-TNF treatment: a prospective study. Inflamm Bowel Dis. 2016;22:1101–1106.
   PubMed Web of Science ®Google Scholar
• Jørgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther. 2010;32:377–383.
   PubMed Web of Science ®Google Scholar
• Narula N, Cooray M, Anglin R, et al. Impact of high-dose vitamin D3 supplementation in patients with Crohn’s disease in remission: a pilot randomized double-blind controlled study. Dig Dis Sci. 2017;62:448–455.
   PubMed Web of Science ®Google Scholar
• Raftery T, Martineau AR, Greiller CL, et al. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: results from a randomised double-blind placebo-controlled study. United European Gastroenterol J. 2015;3:294–302.
   PubMed Web of Science ®Google Scholar
• Sharifi A, Hosseinzadeh-Attar MJ, Vahedi H, et al. A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients. Saudi J Gastroenterol. 2016;22:316–323.
   PubMed Web of Science ®Google Scholar
• Mathur J, Naing S, Mills P, et al. A randomized clinical trial of vitamin D3 (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D3. PeerJ. 2017;5:e3654.
   PubMed Web of Science ®Google Scholar
• Tan B, Li P, Lv H, et al. Treatment of vitamin D deficiency in Chinese inflammatory bowel disease patients: A prospective, randomized, open-label, pilot study. J Dig Dis. 2018;19:215–224.
   PubMed Web of Science ®Google Scholar
• Miheller P, Muzes G, Hritz I, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients. Inflamm Bowel Dis. 2009;15:1656–1662.
   PubMed Web of Science ®Google Scholar
• Garg M, Hendy P, Ding JN, et al. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohns Colitis. 2018;12:963–972.
   PubMed Web of Science ®Google Scholar
• Yang L, Weaver V, Smith JP, et al. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn’s patients. Clin Transl Gastroenterol. 2013;4:e33.
   PubMed Web of Science ®Google Scholar
• Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58..
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
   Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–1930..
   PubMed Web of Science ®Google Scholar
• Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn’s disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995;7:609–614.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther. 1996;10:777–786.
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Ward LM, Gallagher JC, et al. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;45:538–545.
   PubMed Web of Science ®Google Scholar
• Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab. 2012;97:1146–1152.
   PubMed Web of Science ®Google Scholar
• Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387–5391.
   PubMed Web of Science ®Google Scholar
• Heaney RP, Recker RR, Grote J, et al. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab. 2011;96:E447–452.
   PubMed Web of Science ®Google Scholar
• Pappa HM, Mitchell PD, Jiang H, et al. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab. 2012;97:2134–2142.
   PubMed Web of Science ®Google Scholar
• Lin E, Armstrong-Moore D, Liang Z, et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring). 2011;19:588–594.
   PubMed Web of Science ®Google Scholar
• Pramyothin P, Biancuzzo RM, Lu Z, et al. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass. Obesity (Silver Spring). 2011;19:2228–2234.
   PubMed Web of Science ®Google Scholar
• Dadaei T, Safapoor MH, Asadzadeh Aghdaei H, et al. Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients. Gastroenterol Hepatol Bed Bench. 2015;8:49–55.
   PubMedGoogle Scholar